Drugs are safe, active in patients normally ineligible for clinical trial, study suggests

A two-drug combination is safe and active in newly diagnosed acute myeloid leukemia and myelodysplastic syndrome patients who are usually excluded from clinical trials because they have other illnesses or poor performance status -- a measure of disease progression -- researchers report.

Read the whole article on Science Daily

More from Science Daily